IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
Sun Pharma ANZ is a Proprietary Company that generates the majority of its income from the Pharmaceuticals Wholesaling industry. In 2025 the company generated total revenue of $91,113,000 including sales and other revenue. In 2025 Sun Pharma ANZ had 63 employees including employees from all subsidiaries under the company's control. The Chief Executive Officer of Sun Pharma ANZ is either not applicable or not available.The Chairman of Sun Pharma ANZ is either not applicable or not available. Sun Pharma ANZ offer the following products: Specialty Medications Generic Medications Over-the-Counter Medications Active Pharmaceutical Ingredients Anti Retro Viral Medications
Answer any industry question in minutes with our entire database at your fingertips.
Feed trusted, human-driven industry intelligence straight into your platform.
Streamline your workflow with IBISWorld’s intelligence built into your toolkit.
IBISWorld's research coverage on the Sun Pharma Anz Pty Ltd includes market sizing, forecasting, data and analysis. The most recent publication will be as current as of March 2026.
Sun Pharma Anz Pty Ltd, trading as Sun Pharma ANZ, operates under the ABN 17 110 871 826 and was incorporated on 08 September 2004. Sun Pharma Anz Pty Ltd primarily operates in the Pharmaceuticals Wholesaling industry in Australia.
The Key Personnel chapter outlines the principal leadership positions within Sun Pharma Anz Pty Ltd, including the Chairman, Board members, Chief Executive Officer, and other key management personnel. It provides an overview of the company’s governance and executive structure, along with a breakdown of gender diversity across leadership roles, offering insight into the composition of the organisation’s senior team.
The Financials chapter presents Sun Pharma Anz Pty Ltd’s historical financial performance, including detailed profit and loss statements outlining sales revenue, cost of sales, and profitability. It also incorporates balance sheet data, providing a breakdown of assets and liabilities, as well as additional financial metrics such as the number of shares on issue. Together, these disclosures offer a comprehensive view of the company’s financial position and performance over time.
The Growth & Ratios chapter provides historical data on key financial performance indicators, enabling an assessment of the company’s operational efficiency, profitability, and financial structure over time. Metrics covered include return on equity, return on assets, profit margins, revenue per employee, as well as gearing and leverage ratios, offering a comprehensive view of performance trends and capital management.
The Operating Segments chapter provides an overview of the revenue composition and asset allocation across the various industries in which Sun Pharma Anz Pty Ltd operates. It offers insights into how the company’s financial performance is distributed among its core business segments, highlighting the relative contribution of each industry to total revenue.
The Competitor Benchmarking chapter includes a comparative assessment of Sun Pharma Anz Pty Ltd’s key financial, growth, and valuation ratios against industry averages to evaluate its competitive position. It analyses valuation metrics such as price-to-earnings, price-to-book, enterprise value to EBITDA, and enterprise value to sales, alongside core financial indicators including liquidity ratios and profitability measures.
The Industries of Operation chapter outlines Sun Pharma Anz Pty Ltd’s market share across the industries in which it operates. Each industry profile includes a comprehensive overview featuring data on total market size, the number of enterprises, industry concentration levels, and overall turnover. This analysis provides context for the company’s competitive position and scale within each relevant market.
The Shareholders chapter provides a breakdown of the ownership structure of Sun Pharma Anz Pty Ltd, identifying key shareholders and outlining their respective ownership interests. This section offers insight into the concentration of shareholdings, the presence of institutional or strategic investors, and the overall distribution of equity within the company.
The Subsidiaries chapter provides an overview of the companies and business entities that are wholly or partially owned by Sun Pharma Anz Pty Ltd. It outlines the ownership structure of each subsidiary, offering insight into the broader corporate group and how these entities contribute to the company’s overall activities and performance.
The History chapter presents a overview of Sun Pharma Anz Pty Ltd’s development, highlighting key milestones and significant corporate events since its incorporation. It includes the company’s incorporation date and outlines major strategic, operational, and structural developments, providing context for its evolution and current market position.
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
Sun Pharma ANZ offer the following products: Specialty Medications Generic Medications Over-the-Counter Medications Active Pharmaceutical Ingredients Anti Retro Viral Medications
Sun Pharma Anz Pty Ltd, trading as Sun Pharma ANZ, is a Private Company that generates the majority of its income from the Pharmaceuticals Wholesaling industry in Australia.
Murray Cod Australia Limited company is based at 12 Waterloo Road, Macquarie park, New South Wales, Australia.
The DIRECTOR of Sun Pharma Anz Pty Ltd is Akshay Sethi and the DIRECTOR is Wade Mcmonagle.
In 2025, Sun Pharma Anz Pty Ltd generated total revenue of approximately $91.1 million.